ClearPoint Neuro (CLPT) Other Accumulated Expenses (2011 - 2026)

ClearPoint Neuro (CLPT) has 16 years of Other Accumulated Expenses data on file, last reported at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 40.73% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 40.73% YoY), and the FY2025 full-year result was $2.8 million, up 92.14% from the prior year.
• Other Accumulated Expenses declined to $2.1 million in Q1 2026, from $2.8 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $2.8 million in Q4 2025 to a low of $602000.0 in Q1 2022.
• A 5-year average of $1.4 million and a median of $1.3 million in 2024 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses soared 284.54% in 2022 and plunged 49.01% in 2023, its largest moves.
• Tracing CLPT's Other Accumulated Expenses over 5 years: stood at $2.1 million in 2022, then slumped by 49.01% to $1.1 million in 2023, then surged by 37.7% to $1.4 million in 2024, then surged by 92.14% to $2.8 million in 2025, then retreated by 23.73% to $2.1 million in 2026.
• Business Quant data shows CLPT's Other Accumulated Expenses at $2.1 million in Q1 2026, $2.8 million in Q4 2025, and $1.7 million in Q3 2025.